glp 1 agonist depression GLP-1 receptor agonists show promise in treating substance use disorders Do GLP-1 agonists like Ozempic

Read more: To view or add a comment, sign in A new study presented at the European Society of Cardiology Congress 2025, powered by Truveta Data from more than 200,000 patients, found: Early discontinuation was linked to higher cardiovascular risks

Wall M, Kupersmith MJ, Kieburtz KD, et al

Just ask ChatGPT! she says

Conclusions/interpretation In individuals with NAFLD and type 2 diabetes, GLP-1RAs are associated with lower incidences of adverse CVEs and all-cause mortality compared with metformin or other second- and third-line glucose-lowering medications

5 Discussion SID is a frequent complication of GCs therapy, with limited guidance regarding optimal management strategies